Thursday, January 31, 2013
Publication and contact
Transgenic miniature pig
model for hypercholesterolemia and atherosclerosis
A transgenic miniature pig
model for hypercholesterolemia and atherosclerosis could aid the development
of imaging technologies, intravascular devices and therapeutics. Yucatan
miniature pigs were engineered to express a gain-of-function mutant of human proprotein convertase subtilisin/kexin type 9
(PCSK9) in the liver,
which causes hypercholesterolemia and accelerates atherosclerosis in humans.
Transgenic pigs fed a high-fat, high-cholesterol diet had severe
hypercholesterolemia and key pathophysiological features of human
atherosclerosis, and faster development of atherosclerotic lesions compared
with wild-type pigs fed the same diet. Ongoing studies include validating
some of the imaging techniques used for clinical atherosclerosis studies.
SciBX 6(4); doi:10.1038/scibx.2013.99
Published online Jan. 31, 2013
Patent application filed by
licensed to PixieGene A/S
Al-Mashhadi, R.H. et al.
Sci. Transl. Med.; published online Jan. 2, 2013;
Contact: Jacob F. Bentzon, Aarhus University Hospital, Aarhus,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]